Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Stereotactic Body Radiotherapy (SBRT) of the Primary Tumor in Renal Cell Carcinoma (RCC)

NCT02410174 is registered in ClinicalTrials.gov with Beth Israel Medical Center as lead sponsor.

NCT NCT02410174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02410174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Stereotactic Body Radiotherapy (SBRT) of the Primary Tumor in Renal Cell Carcinoma (RCC)
Lead sponsor
Beth Israel Medical Center
Phase
Phase 1
Overall status
Terminated
Start date
May 31, 2012
Completion date
December 31, 2016
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

primary tumor, renal cell carcinoma